Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/23 16:30 | 8/11/23 | SGTX | Health | Drug | Pharmaceutical Preparations | Eli Lilly & Co | IN | T | P | 25,640 | 14.92 | 0 | 1,718 | 0 | D | ||||||||||||||||
7/27/23 16:21 | 7/27/23 | SGTX | Health | Drug | Pharmaceutical Preparations | Yuan Qing Sarah | MA | O | CTOO | M.d | 55 | 19.24 | 0 | 3 | New | 3 | D | ||||||||||||||
7/24/23 19:45 | 7/21/23 | SGTX | Health | Drug | Pharmaceutical Preparations | Pontes Josias | MA | O | CFO | M.d | 28 | 19.24 | 0 | 1 | 80 | 3 | D | ||||||||||||||
7/24/23 19:44 | 7/21/23 | SGTX | Health | Drug | Pharmaceutical Preparations | Vivaldi Coelho Rogerio | MA | DO | P,CEO | M.d | 106 | 19.24 | 0 | 6 | 86 | 12 | D | ||||||||||||||
7/2/21 16:16 | 7/1/21 | SGTX | Health | Drug | Pharmaceutical Preparations | Ruffolo Robert R | MA | D | M.d | 4 | 0.5700 | 0 | 7 | 0 | D | ||||||||||||||||
7/2/21 16:16 | 7/1/21 | SGTX | Health | Drug | Pharmaceutical Preparations | Ruffolo Robert R | MA | D | S.d | -70 | 10.36 | 0 | -7 | -100 | 0 | D | |||||||||||||||
6/4/21 16:15 | 6/2/21 | SGTX | Health | Drug | Pharmaceutical Preparations | Anderson Daniel Griffith | MA | D | S | -2,000 | 10.00 | 0 | -200 | -9 | 2,022 | D | |||||||||||||||
12/10/20 17:00 | 12/8/20 | SGTX | Health | Drug | Pharmaceutical Preparations | Eli Lilly & Co | IN | T | P.d | 5,400 | 18.00 | 0 | 300 | 12 | 2,744 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |